News

Interested in more news from CMIT? Sign up for our newsletter.

Summary: Engineering Phage Host-Range and Suppressing Bacterial Resistance through Phage Tail Fiber Mutagenesis
Performing targeted mutagenesis of specific phage regions that are critical for bacterial recognition, creating diversity at binding regions that slows evolution of bacterial resistance mechanisms.
Summary: Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis
In a recent study, researchers use single cell sequencing of intestinal tissue biopsies from diseased and healthy patients to create a cell atlas that lends novel insight into the cellular pathways that link implicated genes to UC pathophysiology.
Spotlight on Dr. Duane Wesemann, MD, PhD
Interview with Dr. Duane Wesemann, an Assistant Professor at Harvard Medical School, and a Principal investigator in the Division of Rheumatology, Immunology and Allergy at the Brigham and Women’s Hospital.
Summary: Framework for Rational Donor Selection in Fecal Microbiota Transplant Clinical Trials
Fecal Microbiota Transplant (FMT) is gaining traction as a potentially effect treatment of the increasing number of diseases that have been linked to microbiome dysbiosis.
Summary: Mapping Human Microbiome Drug Metabolism by Gut Bacteria and Their Genes
In a recent study published in Nature by Zimmerman (et.al), researchers begin to uncover how intestinal bacteria chemically modify prescription drugs.
Spotlight on Brittany Berdy, PhD
This month I interviewed Brittany Berdy, PhD, who is CMIT’s pinpoint person for their Bio-Microbial Library Strain Collection.
Progressive Shifts in the Gut Microbiome Reflect Prediabetes and Diabetes Development in a Treatment-Naive Mexican Cohort
To look for associations between the gut microbiome composition and development of Type 2 Diabetes, CMIT collaborated with researchers at institutes and hospitals within Mexico to study a cohort that had not been been diagnosed with, or treated for T2D, avoiding the potential influences of medication and lifestyle changes on gut microbes.
CMIT Annual Request for Applications is Open
The Center for Microbiome Informatics and Therapeutics was founded to accelerate the development of therapeutics to treat microbiome-associated disease, with a core focus on Inflammatory Bowel Disease (IBD).
Going for the Gut
Working to preserve human microbiome diversity
Multi-omics of the Gut Microbial Ecosystem in Inflammatory Bowel Diseases
In a recently published paper in Nature, Lloyd-Price (et.al) provide a comprehensive analysis of the longitudinal variation in the gut microbiome of patients with IBD.